Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 6: COVID-19 and the Eye
Submit an article Journal homepage
157
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Reactivation of Graves’ Disease and Thyroid Eye Disease following COVID-19 Vaccination – A Case Report

Chien-Wei Hunga Department of Ophthalmology, Cathay General Hospital, Taipei, TaiwanView further author information
, MD &
Chih-Heng Hunga Department of Ophthalmology, Cathay General Hospital, Taipei, Taiwan;b School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, TaiwanCorrespondence[email protected]
View further author information
, MD
Pages 1286-1290 | Received 22 Nov 2022, Accepted 31 Jan 2023, Published online: 16 Feb 2023

References

  • Caron P. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management. Endocrine. June 28, 2022:1–12. doi:10.1007/s12020-022-03118-4.
  • Chin YH, Ng CH, Lee MH, et al. Prevalence of thyroid eye disease in Graves’ disease: a meta-analysis and systematic review. Clin Endocrinol (Oxf). 2020;93(4):363–374. doi:10.1111/cen.14296.
  • Patel P, Khandji J, Kazim M. Recurrent thyroid eye disease. Ophthal Plast Reconstr Surg. 2015;31(6):445–448. doi:10.1097/IOP.0000000000000371.
  • Rubinstein TJ. Thyroid eye disease following COVID-19 vaccine in a patient with a history of Graves’ disease: a case report. Ophthal Plast Reconstr Surg. 2021;37(6):e221–e223. doi:10.1097/IOP.0000000000002059.
  • Pierman G, Delgrange E, Jonas C. Recurrence of Graves’ disease (a Th1-type cytokine disease) following SARS-CoV-2 mRNA vaccine administration: a simple coincidence? Eur J Case Rep Intern Med. 2021;8(9):002807. doi:10.12890/2021_002807.
  • Goblirsch TJ, Paulson AE, Tashko G, et al. Graves’ disease following administration of second dose of SARS-CoV-2 vaccine. BMJ Case Rep. 2021;14:e246432. doi:10.1136/bcr-2021-246432.
  • KS P, SE F, Ting M, et al. Thyroid eye disease reactivation associated with COVID-19 vaccination. Taiwan J Ophthalmol. 2022;12(1):93–96. doi:10.4103/tjo.tjo_61_21.
  • Bostan H, Ucan B, Kizilgul M, et al. Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: a case series and review of the literature. J Autoimmun. 2022;128:102809. doi:10.1016/j.jaut.2022.102809.
  • Patrizio A, Ferrari SM, Antonelli A, et al. Worsening of Graves’ ophthalmopathy after SARS-CoV-2 mRNA vaccination. Autoimmun Rev. 2022;21(7):103096. doi:10.1016/j.autrev.2022.103096.
  • Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2020;11:617089. doi:10.3389/fimmu.2020.617089.
  • Watad A, Quaresma M, Brown S, et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome) - An update. Lupus. 2017;26(7):675–681. doi:10.1177/0961203316686406.
  • Li Y, Yao Y, Yang M, et al. Association between HLA-B*46 allele and Graves’ disease in Asian populations: a meta-analysis. Int J Med Sci. 2013;10(2):164–170. doi:10.7150/ijms.5158.
  • Fröhlich E, Wahl R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521. doi:10.3389/fimmu.2017.00521.
  • Kyriakos G, Patsouras A, Voutyritsa E, et al. The role of TPOAb in thyroid-associated orbitopathy: a systematic review. Ocul Immunol Inflamm. July 2, 2021: 1–7. doi:10.1080/09273948.2021.1942498.
  • Kuś A, Szymański K, Jurecka-Lubieniecka B, et al. Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves’ ophthalmopathy. J Hum Genet. 2017;62(3):373–377. doi:10.1038/jhg.2016.135.
  • Bartalena L, Kahaly GJ, Baldeschi L, et al. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol. 2021;185(4):G43–G67. doi:10.1530/EJE-21-0479.
  • Gencoglu AY, Mangan MS. Orbital inflammatory pseudotumor following mRNA COVID-19 vaccination. Ocul Immunol Inflamm. August 1, 2022:1–4. doi:10.1080/09273948.2022.2093757.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.